Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide + Dexamethasone in Japanese RRMM
NCT02011113Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Dec 2013
- Primary completion
- Sep 2014
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Dec 2013; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02011113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011113.